Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in non‑small cell lung cancer (Review)

Oncology Reports ◽

10.3892/or.2020.7851 ◽

2020 ◽

Author(s):

Li Wang ◽

Wen Wang

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Anaplastic Lymphoma ◽

Download Full-text

P1.03-010 Efficacy and Safety of Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors in ALK-Positive Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.814 ◽

2017 ◽

Vol 12 (11) ◽

pp. S1954

Author(s):

R. Imase ◽

S. Endo ◽

Y. Sasahara ◽

T. Shinmura ◽

T. Ozawa ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Download Full-text

Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer

Translational Cancer Research ◽

10.21037/tcr.2018.10.23 ◽

2018 ◽

Vol 8 (S1) ◽

pp. S48-S54

Author(s):

Tiziana Vavalà ◽

Annapaola Mariniello ◽

Silvia Novello

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

Significance of alectinib in anaplastic lymphoma kinase-tyrosine kinase inhibitors for anaplastic lymphoma kinase-positive patients with non–small cell lung cancer

Precision Cancer Medicine ◽

10.21037/pcm.2019.12.04 ◽

2020 ◽

Vol 3 ◽

pp. 3-3

Author(s):

Yasuhiro Chikaishi ◽

Kenichi Kobayashi ◽

Hiroki Matsumiya ◽

Akihiro Taira ◽

Yusuke Nabe ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

PCN107 Cost-Effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for NON-SMALL CELL LUNG Cancer in Greece

Value in Health ◽

10.1016/j.jval.2020.08.244 ◽

2020 ◽

Vol 23 ◽

pp. S442

Author(s):

G. Gourzoulidis ◽

O. Zisimopoulou ◽

N. Boubouchairopoulou ◽

C. Michailidi ◽

C. Almond ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Effectiveness Analysis ◽

Previously Treated

Download Full-text

A single center report for safety and efficacy of CT-707 in Chinese patients with advanced, anaplastic lymphoma kinase-rearranged non-small cell lung cancer or other tumours

Annals of Oncology ◽

10.1093/annonc/mdz437.030 ◽

2019 ◽

Vol 30 ◽

pp. ix170

Author(s):

P. Song ◽

L. Zhang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Chinese Patients ◽

Single Center ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Anaplastic Lymphoma ◽

Download Full-text

Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK -Rearranged Non–Small-Cell Lung Cancer: A Retrospective Analysis

Clinical Lung Cancer ◽

10.1016/j.cllc.2016.11.015 ◽

2017 ◽

Vol 18 (4) ◽

pp. e251-e258 ◽

Author(s):

Tetsuhiko Asao ◽

Yutaka Fujiwara ◽

Kota Itahashi ◽

Shinsuke Kitahara ◽

Yasushi Goto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Retrospective Analysis ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Japanese Patients ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

ASCEND-8 pharmacokinetic, safety, and efficacy data for ceritinib 450 mg with food in patients with anaplastic lymphoma kinase–positive non-small cell lung Cancer: A clinical perspective

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2019.100149 ◽

2019 ◽

Vol 20 ◽

pp. 100149 ◽

Author(s):

Salman Otoukesh ◽

Tiffany Sanchez ◽

Saied Mirshahidi ◽

Desiree Wallace ◽

Hamid Mirshahidi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Clinical Perspective ◽

Small Cell Lung ◽

Efficacy Data ◽

Safety And Efficacy ◽

Anaplastic Lymphoma

Download Full-text

Four lines of anaplastic lymphoma kinase inhibitors and brain radiotherapy in a long-surviving non-small-cell lung cancer anaplastic lymphoma kinase-positive patient with leptomeningeal carcinomatosis

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000699 ◽

2019 ◽

Vol 30 (2) ◽

pp. 201-204 ◽

Author(s):

Concetta E. Onesti ◽

Daniela Iacono ◽

Silvia Angelini ◽

Marco Mazzotta ◽

Raffaele Giusti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Leptomeningeal Carcinomatosis ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Brain Radiotherapy

Download Full-text

Pharmacotherapeutic advances with anaplastic lymphoma kinase inhibitors for the treatment of non-small cell lung cancer

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2020.1738387 ◽

2020 ◽

Vol 21 (8) ◽

pp. 931-940 ◽

Author(s):

Alice Indini ◽

Erika Rijavec ◽

Michele Ghidini ◽

Claudia Bareggi ◽

Donatella Gambini ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

Anaplastic lymphoma kinase inhibitors in elderly patients with advanced non-small cell lung cancer

Expert Review of Anticancer Therapy ◽

10.1080/14737140.2016.1204235 ◽

2016 ◽

Vol 16 (8) ◽

pp. 877-883

Author(s):

Mazen Zaarour ◽

Bassel Nazha ◽

Chanudi Weerasinghe ◽

Elias Moussaly ◽

Terenig Terjanian

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text